Market Pulse
Daily · Sep 17, 2026 · data.go.kr + ECOS
KOSPI
6,715.41
-2.56 (-0.04%)
KOSDAQ
822.18
+6.20 (+0.76%)
KOSPI 200
1,058.27
-1.78 (-0.17%)
USD/KRW
1,382.20
185750KOSPI·Feb 27, 2026
Atrial fibrillation asset newly reflected in pipeline value
Mirae Asset Securities published a company analysis report on Chong Kun Dang Pharmaceutical Corp. (185750) titled "Atrial fibrillation asset newly reflected in pipeline value".
Summary
Covers Chong Kun Dang Pharmaceutical Corp. (185750).
Covered stock
More on 185750
Limited earnings improvement, but pipeline development on trackMirae Asset Securities · Aug 24, 2026Earnings Stable; R&D Also Steadily in ProgressKB Securities · Nov 04, 2025Focus on the potential of HDAC6 inhibitorMirae Asset Securities · Aug 05, 2025Focus on clinical trial plans for CKD-510Mirae Asset Securities · Feb 04, 2025